NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Details

Serval ID
serval:BIB_B5E270CD6FAF
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
Journal
Journal of the National Comprehensive Cancer Network
Author(s)
Haddad R.I., Nasr C., Bischoff L., Busaidy N.L., Byrd D., Callender G., Dickson P., Duh Q.Y., Ehya H., Goldner W., Haymart M., Hoh C., Hunt J.P., Iagaru A., Kandeel F., Kopp P., Lamonica D.M., McIver B., Raeburn C.D., Ridge J.A., Ringel M.D., Scheri R.P., Shah J.P., Sippel R., Smallridge R.C., Sturgeon C., Wang T.N., Wirth L.J., Wong R.J., Johnson-Chilla A., Hoffmann K.G., Gurski L.A.
ISSN
1540-1413 (Electronic)
ISSN-L
1540-1405
Publication state
Published
Issued date
12/2018
Peer-reviewed
Oui
Volume
16
Number
12
Pages
1429-1440
Language
english
Notes
Publication types: Journal Article ; Practice Guideline ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E-mutated anaplastic thyroid carcinoma.
Keywords
Antineoplastic Combined Chemotherapy Protocols/standards, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biomarkers, Tumor/analysis, Biomarkers, Tumor/genetics, Biomarkers, Tumor/metabolism, Carcinoma/diagnosis, Carcinoma/mortality, Carcinoma/pathology, Carcinoma/therapy, Clinical Trials as Topic, Humans, Image-Guided Biopsy/methods, Image-Guided Biopsy/standards, Medical Oncology/standards, Neoplasm Staging, Prognosis, Protein Kinase Inhibitors/standards, Protein Kinase Inhibitors/therapeutic use, Proto-Oncogene Proteins B-raf/antagonists & inhibitors, Proto-Oncogene Proteins B-raf/genetics, Societies, Medical/standards, Thyroid Gland/diagnostic imaging, Thyroid Gland/pathology, Thyroid Gland/surgery, Thyroid Neoplasms/diagnosis, Thyroid Neoplasms/genetics, Thyroid Neoplasms/pathology, Thyroid Neoplasms/therapy, Thyroidectomy/methods, Thyroidectomy/standards, Treatment Outcome, United States
Pubmed
Web of science
Open Access
Yes
Create date
16/12/2020 21:51
Last modification date
17/12/2020 6:26
Usage data